DE2946275A1 - Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen - Google Patents

Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen

Info

Publication number
DE2946275A1
DE2946275A1 DE19792946275 DE2946275A DE2946275A1 DE 2946275 A1 DE2946275 A1 DE 2946275A1 DE 19792946275 DE19792946275 DE 19792946275 DE 2946275 A DE2946275 A DE 2946275A DE 2946275 A1 DE2946275 A1 DE 2946275A1
Authority
DE
Germany
Prior art keywords
interferon
cells
stimulator
prodn
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19792946275
Other languages
German (de)
English (en)
Other versions
DE2946275C2 (enExample
Inventor
Günther Wien Adolf
Gerhard Dr. Bodo
Peter Dr. Swetly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Priority to DE19792946275 priority Critical patent/DE2946275A1/de
Priority to AT0506880A priority patent/AT374828B/de
Publication of DE2946275A1 publication Critical patent/DE2946275A1/de
Application granted granted Critical
Publication of DE2946275C2 publication Critical patent/DE2946275C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19792946275 1979-11-16 1979-11-16 Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen Granted DE2946275A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19792946275 DE2946275A1 (de) 1979-11-16 1979-11-16 Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen
AT0506880A AT374828B (de) 1979-11-16 1980-10-13 Verfahren zur herstellung von humaninterferon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792946275 DE2946275A1 (de) 1979-11-16 1979-11-16 Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen

Publications (2)

Publication Number Publication Date
DE2946275A1 true DE2946275A1 (de) 1981-05-27
DE2946275C2 DE2946275C2 (enExample) 1987-11-05

Family

ID=6086143

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19792946275 Granted DE2946275A1 (de) 1979-11-16 1979-11-16 Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen

Country Status (2)

Country Link
AT (1) AT374828B (enExample)
DE (1) DE2946275A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038920A1 (de) * 1980-04-26 1981-11-04 Messerschmitt-Bölkow-Blohm Gesellschaft mit beschränkter Haftung Gasgefüllter Fahrzeugreifen
CN115210364A (zh) * 2019-09-25 2022-10-18 马尔堡菲利普大学 短链脂肪酸戊酸作为细胞疗法和抗肿瘤疗法的增强剂

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3930140A1 (de) * 1989-09-09 1991-03-21 Bayer Ag Verfahren zur herstellung von biologischen materialien in zellkulturen und vorrichtungen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000520A1 (en) * 1977-07-15 1979-02-07 The Wellcome Foundation Limited Improvement in or relating to a process for producing interferon

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000520A1 (en) * 1977-07-15 1979-02-07 The Wellcome Foundation Limited Improvement in or relating to a process for producing interferon

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Acta Virol. 19, 250 (1975) *
International Journal of Cancer 6, 436 (1970) *
J. of Clinical Microbiology 1, 116 (1975) *
J. Virol. 7, 792 (1971) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038920A1 (de) * 1980-04-26 1981-11-04 Messerschmitt-Bölkow-Blohm Gesellschaft mit beschränkter Haftung Gasgefüllter Fahrzeugreifen
CN115210364A (zh) * 2019-09-25 2022-10-18 马尔堡菲利普大学 短链脂肪酸戊酸作为细胞疗法和抗肿瘤疗法的增强剂

Also Published As

Publication number Publication date
AT374828B (de) 1984-06-12
ATA506880A (de) 1983-10-15
DE2946275C2 (enExample) 1987-11-05

Similar Documents

Publication Publication Date Title
DE3688841T2 (de) Schwache interferondosierung für die erhöhung der impfstoffwirksamkeit.
DE3520228C2 (de) Wasserlösliche bioaktive Trockenfeststoffzusammensetzung, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
EP0352500B1 (de) Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen immunoglobulin-Präparates mit hohemIgM-Gehalt.
DE3689246T2 (de) Physiologisch aktives Polypeptid BUF-3.
EP0005476B1 (de) Verfahren zur Herstellung von Humaninterferon
US4216203A (en) Process for producing interferon
DD209477A5 (de) Verfahren zur herstellung von mikroorganismen
DE3704389C2 (enExample)
DE69329841T2 (de) Verfahren zur Unterdrückung der Koloration von menschlichem Serum-Albumin
DE2930604C2 (de) Verwendung von doppelstrangiger Ribonucleinsäure als Interferon-Induktor
DE69430975T2 (de) Verfahren zur Herstellung von Proteinen
DE3600083C2 (de) Verwendung von alpha-Interferon zur Behandlung des respiratorischen Erkrankungskomplexes bei Rindern
DE2946275C2 (enExample)
EP0062085B1 (de) Verbessertes Verfahren zur Herstellung von Humaninterferon aus lymphoblastoiden Zellen
DE3434122C2 (enExample)
HU189706B (en) Improved process for the production of interferon
DE2821466A1 (de) Verbessertes verfahren zur herstellung von humaninterferon
DE68928138T2 (de) Neuer megakaryokytischer koloniestimulierender faktor und verfahren zur herstellung
DE3249215C2 (de) Verfahren zur herstellung von humanem gamma-interferon.
CH646875A5 (de) Verfahren zur gewinnung eines interferons und interferon hergestellt nach diesem verfahren.
DE2724918A1 (de) Gewinnung und reinigung von humaninterferon
DE69103053T2 (de) Pharmazeutische Zubereitung für die Reifung von Prothymozythen.
DE69022606T2 (de) Menschlichen Monozyt-Makrophagen-Koloniestimulierungsfaktor enthaltende Zusammensetzung.
DE2404265B2 (de) Verfahren zum Anreichern von Immunglobulinen
DE19512227C1 (de) Multifaktorielles Abwehr-Modulatorengemisch, Verfahren zu seiner Herstellung und diese Modulatoren enthaltende Arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee